This is a contrast between Provention Bio Inc. (NASDAQ:PRVB) and Intec Pharma Ltd. (NASDAQ:NTEC) based on their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. The two companies are Biotechnology and they also compete with each other.

Earnings and Valuation

Table 1 shows the top-line revenue, earnings per share and valuation for Provention Bio Inc. and Intec Pharma Ltd.

Profitability

Table 2 demonstrates the return on assets, return on equity and net margins of Provention Bio Inc. and Intec Pharma Ltd.

Insider Institutional Ownership

Roughly 6.7% of Provention Bio Inc. shares are owned by institutional investors while 40.62% of Intec Pharma Ltd. are owned by institutional investors. 31% are Provention Bio Inc.’s share owned by insiders. Competitively, Intec Pharma Ltd. has 11.4% of it’s share owned by insiders.

Performance

In this table we show the Weekly, Monthly, Quarterly,

... read more at: https://hinewulm.com/2019/02/13/reviewing-provention-bio-inc-prvbs-and-intec-pharma-ltd-nasdaqntecs-results/